Ray Therapeutics
San Diego, California, United States · Biotechnology, Health Care, Science And Engineering
Ray Therapeutics Inc (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and will not require light-enhancing goggles). Our studies have shown for the first time that our proprietary ChRown optogenetic protein can restore high levels of visual acuity, contra
Key facts
- Headquarters
- San Diego, California, United States
- Employees
- 33
- Industries
- Biotechnology, Health Care, Science And Engineering
- Status
- Private
- Website
- raytherapeutics.com
- Company page
Recent activity at Ray Therapeutics
- : Ray Therapeutics receives $8M grant from CIRM to advance optogenetic gene therapy for Stargardt disease. (date Fundz recorded it)
- : Ray Therapeutics secures $125 Million Series B financing led by Janus Henderson Investors to advance vision restoration treatments.
- : Ray Therapeutics Appoints Christopher Whitmore as Chief Financial Officer
- : Ray Therapeutics Announces Promotion of Jenny Holt to Chief Development Officer
- : Ray Therapeutics
- : Ray Therapeutics, Inc.
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Ray Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Apr 2026 | Series B | $125.0M |
| May 2023 | Venture | $14.0M |
| Apr 2022 | Venture | $6.0M |
Leadership
- Vidya Sundararaman, Sr Director, CMC Analytical
- Jerrod Denham, VP, Cmc
- Christopher Whitmore, Chief Financial Officer
- Jenny Holt, Chief Development Officer
Verified email and direct lines for Ray Therapeutics’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
Ray Therapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Companies similar to Ray Therapeutics
- Saol Therapeutics · Biotechnology, Health Care, Science And Engineering
- Cardiff Oncology · Biotechnology, Health Care, Science And Engineering
- Electra Therapeutics · Biotechnology, Health Care, Science And Engineering
- AN2 Therapeutics · Biotechnology, Health Care, Science And Engineering
- PineTree Therapeutics · Biotechnology, Health Care, Science And Engineering
About Ray Therapeutics: questions and answers
What does Ray Therapeutics do?
Ray Therapeutics Inc (RayTx) is a late-stage preclinical Bay Area biotechnology company pioneering the first-to-market precision optogenetic therapy for vision restoration that is highly active in ambient lighting (and will not require light-enhancing goggles). Our studies have shown for the first time that our proprietary ChRown optogenetic protein can restore high levels of visual acuity, contra
Where is Ray Therapeutics headquartered?
Ray Therapeutics is headquartered in San Diego, California, United States.
How many employees does Ray Therapeutics have?
Ray Therapeutics has about 33 employees.
Has Ray Therapeutics raised funding?
Yes. Fundz has recorded 3 funding events for Ray Therapeutics. The most recent, Series B of $125.0M, was in Apr 2026.
What is the latest news on Ray Therapeutics?
On Oct 1, 2026, Ray Therapeutics receives $8M grant from CIRM to advance optogenetic gene therapy for Stargardt disease.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy